Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 370 entries
Sorted by: Best Match Show Resources per page
GALEN in action.

IAPAC monthly

[No authors listed]
PMID: 12510662
IAPAC Mon. 2002 Oct;8(10):289.

No abstract available.

Cite
GALEN in action. IAPAC Mon. 2002;8(10):289
(2002). GALEN in action. IAPAC monthly, 8(10), 289.
"GALEN in action." IAPAC monthly vol. 8,10 (2002): 289.
GALEN in action. IAPAC Mon. 2002 Oct;8(10):289. PMID: 12510662.
Copy Download .nbib Format: NLM
Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Wanke CA, Falutz JM, Shevitz A, Phair JP, Kotler DP.
PMID: 11740715
Clin Infect Dis. 2002 Jan 15;34(2):248-59. doi: 10.1086/324744. Epub 2001 Dec 07.

In recent years, a spectrum of metabolic and morphologic alterations has emerged among patients infected with human immunodeficiency virus (HIV) receiving antiretroviral treatment. Changes observed include insulin resistance, dyslipidemia, abdominal and dorsocervical fat accumulation, and fat depletion in the...

Cite
Wanke CA, Falutz JM, Shevitz A, et al. Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus. Clin Infect Dis. 2001;34(2):248-59doi: 10.1086/324744.
Wanke, C. A., Falutz, J. M., Shevitz, A., Phair, J. P., & Kotler, D. P. (2002). Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34(2), 248-59. https://doi.org/10.1086/324744
Wanke, Christine A, et al. "Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 34,2 (2002): 248-59. doi: https://doi.org/10.1086/324744
Wanke CA, Falutz JM, Shevitz A, Phair JP, Kotler DP. Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus. Clin Infect Dis. 2002 Jan 15;34(2):248-59. doi: 10.1086/324744. Epub 2001 Dec 07. PMID: 11740715.
Copy Download .nbib Format: NLM
Treatment of primary HIV infection.

MedGenMed : Medscape general medicine

Daar ES.
PMID: 12817211
MedGenMed. 2002 Nov 15;4(4):15.

No abstract available.

Cite
Daar ES. Treatment of primary HIV infection. MedGenMed. 2002;4(4):15
Daar, E. S. (2002). Treatment of primary HIV infection. MedGenMed : Medscape general medicine, 4(4), 15.
Daar, Eric S. "Treatment of primary HIV infection." MedGenMed : Medscape general medicine vol. 4,4 (2002): 15.
Daar ES. Treatment of primary HIV infection. MedGenMed. 2002 Nov 15;4(4):15. PMID: 12817211.
Copy Download .nbib Format: NLM
Heart disease and HIV: the ongoing debate.

Positively aware : the monthly journal of the Test Positive Aware Network

Sharp M.
PMID: 12866488
Posit Aware. 2003 May-Jun;14(3):24, 37.

No abstract available.

Cite
Sharp M. Heart disease and HIV: the ongoing debate. Posit Aware. 2003;14(3):24, 37
Sharp, M. (2003). Heart disease and HIV: the ongoing debate. Positively aware : the monthly journal of the Test Positive Aware Network, 14(3), 24, 37.
Sharp, Matt. "Heart disease and HIV: the ongoing debate." Positively aware : the monthly journal of the Test Positive Aware Network vol. 14,3 (2003): 24, 37.
Sharp M. Heart disease and HIV: the ongoing debate. Posit Aware. 2003 May-Jun;14(3):24, 37. PMID: 12866488.
Copy Download .nbib Format: NLM
HAART patients at greater risk of severe side effects than AIDS.

IAPAC monthly

Carter M.
PMID: 15055163
IAPAC Mon. 2003 Dec;9(12):314.

No abstract available.

Cite
Carter M. HAART patients at greater risk of severe side effects than AIDS. IAPAC Mon. 2003;9(12):314
Carter, M. (2003). HAART patients at greater risk of severe side effects than AIDS. IAPAC monthly, 9(12), 314.
Carter, Michael. "HAART patients at greater risk of severe side effects than AIDS." IAPAC monthly vol. 9,12 (2003): 314.
Carter M. HAART patients at greater risk of severe side effects than AIDS. IAPAC Mon. 2003 Dec;9(12):314. PMID: 15055163.
Copy Download .nbib Format: NLM
Cancer. Trends in cancer risk among women with HIV/AIDS.

TreatmentUpdate

[No authors listed]
PMID: 17219674
TreatmentUpdate. 2004 Jun-Jul;16(4):5-6.

No abstract available.

Cite
Cancer. Trends in cancer risk among women with HIV/AIDS. TreatmentUpdate. 2004;16(4):5-6
(2004). Cancer. Trends in cancer risk among women with HIV/AIDS. TreatmentUpdate, 16(4), 5-6.
"Cancer. Trends in cancer risk among women with HIV/AIDS." TreatmentUpdate vol. 16,4 (2004): 5-6.
Cancer. Trends in cancer risk among women with HIV/AIDS. TreatmentUpdate. 2004 Jun-Jul;16(4):5-6. PMID: 17219674.
Copy Download .nbib Format: NLM
Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention.

The American journal of gastroenterology

Berretta M, Tirelli U.
PMID: 16635238
Am J Gastroenterol. 2006 Apr;101(4):907; author reply 907-8. doi: 10.1111/j.1572-0241.2006.00511.x.

No abstract available.

Cite
Berretta M, Tirelli U. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol. 2006;101(4):907; author reply 907-8doi: 10.1111/j.1572-0241.2006.00511.x.
Berretta, M., & Tirelli, U. (2006). Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. The American journal of gastroenterology, 101(4), 907; author reply 907-8. https://doi.org/10.1111/j.1572-0241.2006.00511.x
Berretta, Massimiliano, and Tirelli, Umberto. "Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention." The American journal of gastroenterology vol. 101,4 (2006): 907; author reply 907-8. doi: https://doi.org/10.1111/j.1572-0241.2006.00511.x
Berretta M, Tirelli U. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol. 2006 Apr;101(4):907; author reply 907-8. doi: 10.1111/j.1572-0241.2006.00511.x. PMID: 16635238.
Copy Download .nbib Format: NLM
Early intervention for metabolic complications of HIV. A healthy lifestyle and treatment early on may prevent complications down the road.

Positively aware : the monthly journal of the Test Positive Aware Network

Heiser CR, Barrett JT.
PMID: 16610126
Posit Aware. 2006 Mar-Apr;17(2):35-41.

No abstract available.

Cite
Heiser CR, Barrett JT. Early intervention for metabolic complications of HIV. A healthy lifestyle and treatment early on may prevent complications down the road. Posit Aware. 2006;17(2):35-41
Heiser, C. R., & Barrett, J. T. (2006). Early intervention for metabolic complications of HIV. A healthy lifestyle and treatment early on may prevent complications down the road. Positively aware : the monthly journal of the Test Positive Aware Network, 17(2), 35-41.
Heiser, Carla R, and Barrett, James T. "Early intervention for metabolic complications of HIV. A healthy lifestyle and treatment early on may prevent complications down the road." Positively aware : the monthly journal of the Test Positive Aware Network vol. 17,2 (2006): 35-41.
Heiser CR, Barrett JT. Early intervention for metabolic complications of HIV. A healthy lifestyle and treatment early on may prevent complications down the road. Posit Aware. 2006 Mar-Apr;17(2):35-41. PMID: 16610126.
Copy Download .nbib Format: NLM
[Treatment of HIV infection in 2006: highlights].

Revue medicale suisse

Schiffer V, Hirschel B.
PMID: 17354665
Rev Med Suisse. 2007 Jan 10;3(93):69-74.

In developed countries, drug therapy has turned HIV infection into a chronic disease. More is known about viral replication and new, easily tolerated drugs will enter the marketplace in 2007 and 2008. For the majority of patients who suffer...

Cite
Schiffer V, Hirschel B. VIH--sida. Traitement de l'infection à VIH en 2006: points forts. [Treatment of HIV infection in 2006: highlights]. Rev Med Suisse. 2007;3(93):69-74
Schiffer, V., & Hirschel, B. (2007). VIH--sida. Traitement de l'infection à VIH en 2006: points forts. [Treatment of HIV infection in 2006: highlights]. Revue medicale suisse, 3(93), 69-74.
Schiffer, V, and Hirschel, B. "VIH--sida. Traitement de l'infection à VIH en 2006: points forts." [Treatment of HIV infection in 2006: highlights]. Revue medicale suisse vol. 3,93 (2007): 69-74.
Schiffer V, Hirschel B. VIH--sida. Traitement de l'infection à VIH en 2006: points forts. [Treatment of HIV infection in 2006: highlights]. Rev Med Suisse. 2007 Jan 10;3(93):69-74. French. PMID: 17354665.
Copy Download .nbib Format: NLM
How I became my doctor's free continuing medical education provider.

Positively aware : the monthly journal of the Test Positive Aware Network

Perez CA.
PMID: 16220607
Posit Aware. 2005 Sep-Oct;16(5):43-4.

No abstract available.

Cite
Perez CA. How I became my doctor's free continuing medical education provider. Posit Aware. 2005;16(5):43-4
Perez, C. A. (2005). How I became my doctor's free continuing medical education provider. Positively aware : the monthly journal of the Test Positive Aware Network, 16(5), 43-4.
Perez, Carlos A. "How I became my doctor's free continuing medical education provider." Positively aware : the monthly journal of the Test Positive Aware Network vol. 16,5 (2005): 43-4.
Perez CA. How I became my doctor's free continuing medical education provider. Posit Aware. 2005 Sep-Oct;16(5):43-4. PMID: 16220607.
Copy Download .nbib Format: NLM
HRS issues grants to combat AIDS.

AIDS policy & law

[No authors listed]
PMID: 15008115
AIDS Policy Law. 2004 Jan 30;19(2):1.

No abstract available.

Cite
HRS issues grants to combat AIDS. AIDS Policy Law. 2004;19(2):1
(2004). HRS issues grants to combat AIDS. AIDS policy & law, 19(2), 1.
"HRS issues grants to combat AIDS." AIDS policy & law vol. 19,2 (2004): 1.
HRS issues grants to combat AIDS. AIDS Policy Law. 2004 Jan 30;19(2):1. PMID: 15008115.
Copy Download .nbib Format: NLM
Highly active antiretroviral therapy for HIV infection: lessons for the future.

The Netherlands journal of medicine

Burger DM, van der Ven AJ, Koopmans PP.
PMID: 15685891
Neth J Med. 2004 Dec;62(11):407-8.

HIV-related morbidity and mortality has been greatly reduced since the introduction of highly active antiretroviral therapy. Issues regarding the patient, the virus, the drugs and the treatment team are discussed. HIV treatment remains complex with a rapidly changing field...

Cite
Burger DM, van der Ven AJ, Koopmans PP. Highly active antiretroviral therapy for HIV infection: lessons for the future. Neth J Med. 2004;62(11):407-8
Burger, D. M., van der Ven, A. J., & Koopmans, P. P. (2004). Highly active antiretroviral therapy for HIV infection: lessons for the future. The Netherlands journal of medicine, 62(11), 407-8.
Burger, D M, et al. "Highly active antiretroviral therapy for HIV infection: lessons for the future." The Netherlands journal of medicine vol. 62,11 (2004): 407-8.
Burger DM, van der Ven AJ, Koopmans PP. Highly active antiretroviral therapy for HIV infection: lessons for the future. Neth J Med. 2004 Dec;62(11):407-8. PMID: 15685891.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 370 entries